Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 1;109(7):1886-94.
doi: 10.1038/bjc.2013.528. Epub 2013 Sep 5.

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers

Affiliations

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers

A R Green et al. Br J Cancer. .

Abstract

Background: Breast cancer is a heterogeneous disease characterised by complex molecular alterations underlying the varied behaviour and response to therapy. However, translation of cancer genetic profiling for use in routine clinical practice remains elusive or prohibitively expensive. As an alternative, immunohistochemical analysis applied to routinely processed tissue samples could be used to identify distinct biological classes of breast cancer.

Methods: In this study, 1073 archival breast tumours previously assessed for 25 key breast cancer biomarkers using immunohistochemistry and classified using clustering algorithms were further refined using naïve Bayes classification performance. Criteria for class membership were defined using the expression of a reduced panel of 10 proteins able to identify key molecular classes. We examined the association between these breast cancer classes with clinicopathological factors and patient outcome.

Results: We confirm patient classification similar to established genotypic biological classes of breast cancer in addition to novel sub-divisions of luminal and basal tumours. Correlations between classes and clinicopathological parameters were in line with expectations and showed highly significant association with patient outcome. Furthermore, our novel biological class stratification provides additional prognostic information to the Nottingham Prognostic Index.

Conclusion: This study confirms that distinct molecular phenotypes of breast cancer can be identified using robust and routinely available techniques and both the luminal and basal breast cancer phenotypes are heterogeneous and contain distinct subgroups.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biplots of classes projected on the first and second principal component axes: (A) for all patients and (B) for only patients assigned to a class.
Figure 2
Figure 2
Breast cancer biological classes. (A) Classification and proportions of cases. (B) Representative immunohistochemical profiles of the biological classes of breast cancer.
Figure 3
Figure 3
Breast cancer biological classes in relation to (A) 5-, (B) 20-year breast cancer-specific survival and (C) 5-, (D) 20-year disease-free survival.
Figure 4
Figure 4
Boxplots of NPI by biological class.

References

    1. Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005;116 (3:340–3450. - PubMed
    1. Abd El-Rehim DM, Pinder SE, Paish CE, Bell JA, Rampaul RS, Blamey RW, Robertson JF, Nicholson RI, Ellis IO. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer. 2004;91 (8:1532–1542. - PMC - PubMed
    1. Al-Daoud M, Roberts S. New methods for the initialisation of clusters. Pattern Recogn Lett. 1996;17 (5:451–455.
    1. Anderberg MR. Monographs and Textbooks on Probability and Mathematical Statistics. Academic Press, Inc.: New York; 1973. Cluster Analysis for Applications.
    1. Ambrogi F, Biganzoli E, Querzoli P, Ferretti S, Boracchi P, Alberti S, Marubini E, Nenci I. Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods. Clin Cancer Res. 2006;12 (3 Pt 1:781–790. - PubMed

Publication types